Profusa, Inc. Common Stock
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor gluco… Read more
Market Cap & Net Worth: Profusa, Inc. Common Stock (PFSA)
Profusa, Inc. Common Stock (NASDAQ:PFSA) has a market capitalization of $34.66 Million ($34.66 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29593 globally and #9799 in its home market, demonstrating a -7.05% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Profusa, Inc. Common Stock's stock price $0.83 by its total outstanding shares 41759307 (41.76 Million).
Profusa, Inc. Common Stock Market Cap History: 2025 to 2026
Profusa, Inc. Common Stock's market capitalization history from 2025 to 2026. Data shows growth from $4.38 Million to $34.66 Million (0.00% CAGR).
Profusa, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Profusa, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PFSA by Market Capitalization
Companies near Profusa, Inc. Common Stock in the global market cap rankings as of March 18, 2026.
Key companies related to Profusa, Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Profusa, Inc. Common Stock Historical Marketcap From 2025 to 2026
Between 2025 and today, Profusa, Inc. Common Stock's market cap moved from $4.38 Million to $ 34.66 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $34.66 Million | +692.08% |
| 2025 | $4.38 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Profusa, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $34.66 Million USD |
| MoneyControl | $34.66 Million USD |
| MarketWatch | $34.66 Million USD |
| marketcap.company | $34.66 Million USD |
| Reuters | $34.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.